Why the Immutep (ASX:IMM) share price is leaping 5% today

Immutep is one step closer to finishing its TACTI-002 trial.
The post Why the Immutep (ASX:IMM) share price is leaping 5% today appeared first on The Motley Fool Australia. –

The Immutep Ltd (ASX: IMM) share price is gaining today following news of the company’s Two ACTive Immunotherapies (TACTI-002) trial.

Recruitment for the trial’s stage 2 of part B is now officially complete.

Right now, the Immutep share price is 55.5 cents, 4.72% higher than its previous close. Additionally, the company’s shares are flying off the shelf.

At the time of writing, more than 1.6 million Immutep shares have swapped hands today. For comparison, an average month sees slightly more than 1.7 million of the company’s securities traded.

Let’s take a closer look at today’s news from the biotech company.

Immutep finishes part B recruitment

The Immutep share price is in the green today on news its TACTI-002 trial’s stage 2 of its part B can begin.

The company has managed to recruit a milestone 154 non-small cell lung cancer (NSCLC) patients for its trial. The now-enrolled patients represent 84% of the participants needed to complete the trial.

Immutep is continuing to recruit patients for the trial’s part A’s expansion phase.

The trial is operating at 19 clinical sites across Australia, Europe, the United States, and the United Kingdom.

It’s evaluating the combination of Immutep’s efti with Merck and Co.‘s KEYTRUDA (pembrolizumab) in patients with second line head and neck squamous cell carcinoma or non-small cell lung cancer in first and second line.

So far, the company believes it has presented encouraging data from the trial’s first stages.

It plans to present more data from the trial at a scientific conference in late 2021 or early 2022.

Immutep share price snapshot

The Immutep share price has been performing well on the ASX lately.

It is currently 33.3% higher than it was at the start of 2021. It has also gained 192% since this time last year.

The company has a market capitalisation of around $472 million, with approximately 850 million shares outstanding.

The post Why the Immutep (ASX:IMM) share price is leaping 5% today appeared first on The Motley Fool Australia.

Should you invest $1,000 in Immutep right now?

Before you consider Immutep, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Immutep wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Immutep (ASX:IMM) share price jumps 5% on Chinese patent grant
Why the Immutep (ASX:IMM) share price is charging higher today

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!